Fig. 3From: Reliable FASP-based procedures for optimal quantitative proteomic and phosphoproteomic analysis on samples from acute myeloid leukemia patientsPhosphoproteome analysis of three AML patient samples. a Number of quantified phosphopeptides with normalized SILAC ratios by MaxQuant and class I-localized phosphosites. b Distribution of serine-, threonine- and tyrosine-phosphosites; and mono-, di- and multi-phosphopeptides in the quantified phosphoproteome. c Molecular function enrichment analysis using the FunRich databaseBack to article page